Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Blue Jet Healthcare gains 8% post Q4; analysts split on near-term prospects
Emkay Global has retained its 'Reduce' rating, while Motilal Oswal has maintained its 'Buy' stance, reflecting contrasting expectations on recovery in key business segments and the margin trajectory
Motilal Oswal sector of the week: Internet; here's why Eternal is top bet
Over the past two years, the industry has moved decisively toward ticket monetisation, with tickets now contributing roughly 50-70 per cent of event revenues compared to 10-30 per cent earlier
Expert View | Retail investors should prioritise portfolio resilience over aggression: Siddhartha Khemka, Motilal Oswal - Mint
Expert View | Retail investors should prioritise portfolio resilience over aggression: Siddhartha Khemka, Motilal OswalMint
Jubilant FoodWorks: Target Slashed; Motilal Oswal Stays Neutral on Soft Q4 Results — Check Upside
Motilal Oswal has trimmed its target price on Jubilant FoodWorks, while maintaining a Neutral' rating, citing a weak Q4 performance and continued near-term pressure on margins.
Six out of 16 Lenskart analysts see the stock beyond ₹600 after Q4 results; Details here
Equirus Securities has the highest target for Lenskart at ₹662, followed by Motilal Oswal at ₹650. Axis Capital, Goldman Sachs, Emkay and Jefferies make up that list.
Lenskart Sees Target Price Hike After Q4 Beat — Check Upside, Key Triggers and More By Motilal Oswal
Lenskart remains a well-positioned consumer-tech play with scalable growth drivers, supported by its integrated business model and expanding global footprint: Motilal Oswal
Zydus Lifesciences shares soar 7% to fresh record high after Q4 results. Should you buy, sell or hold?
Zydus Lifesciences shares climbed to a new 52-week high. The company reported a 9% rise in net profit and over 16% revenue growth for the January-March quarter. A Rs 1,100 crore share buyback was announced. Analysts from Nomura, Nuvama, Motilal Oswal, and JM Financial shared their views on the company's performance and future prospects.
Volume Shocker: MFs added 1 crore+ shares to 9 stocks in April '26; shares rally up to 55%
ETMarkets’ mutual fund analysis highlights 43 stocks with strong share additions in April 2026 versus March 2026, with nine names emerging after a performance filter. Eternal and Vodafone Idea led inflows, while select stocks showed sharp gains driven by sustained institutional buying and strong price momentum.
VolumeShocker:MFsadded1crore+sharesto9stocksinApril'26; sharesrallyupto55%
ETMarkets’ mutual fund analysis highlights 43 stocks with strong share additions in April 2026 versus March 2026, with nine names emerging after a performance filter. Eternal and Vodafone Idea led inflows, while select stocks showed sharp gains driven by sustained institutional buying and strong price momentum.
Retail SIP boom boosts AMC outlook; Nippon, ICICI Pru lead pack: Siddhartha Khemka
India's asset management sector is transforming with systematic investing driving growth and stability, reducing reliance on volatile discretionary capital. SIP inflows have surged, now forming a significant portion of mutual fund assets, indicating a shift towards predictable, annuity-like revenue streams. This structural change positions the industry for sustained, retail-led expansion.
Nifty Bank falls 500 points as PNB, Canara Bank, SBI, other stocks decline up to 3%. What lies ahead?
Indian bank stocks tumbled, dragging the Nifty Bank index down as a weakening rupee and rising global bond yields soured market sentiment. Several major banks saw significant declines, with analysts pointing to key technical levels. The rupee hit an all-time low against the dollar, exacerbating concerns for the financial sector.
Trade Setup For May 18: Nifty Faces Critical Support At 23,500 Amid Weak Global Cues; Check Key Levels
On the flipside, the immediate resistance for Nifty is placed in the 23,800-23,850 zone.